http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 17:04:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+GOGGINS+COLLEEN+A/26780479.html si-local-file:///var/storage/secattach/20260716/26780479.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+GOGGINS+COLLEEN+A/26780479.html Thu, 16 Jul 2026 17:04:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+GOGGINS+COLLEEN+A/26780479.html si-local-file:///var/storage/secattach/20260716/26780479.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+GOGGINS+COLLEEN+A/26780479.html Thu, 16 Jul 2026 17:04:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Wims+Morris+Leslie/26780482.html si-local-file:///var/storage/secattach/20260716/26780482.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Wims+Morris+Leslie/26780482.html Thu, 16 Jul 2026 17:04:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Wims+Morris+Leslie/26780482.html si-local-file:///var/storage/secattach/20260716/26780482.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Wims+Morris+Leslie/26780482.html Thu, 16 Jul 2026 17:04:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+DANHAKL+JOHN+G/26780471.html si-local-file:///var/storage/secattach/20260716/26780471.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+DANHAKL+JOHN+G/26780471.html Thu, 16 Jul 2026 17:03:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+DANHAKL+JOHN+G/26780471.html si-local-file:///var/storage/secattach/20260716/26780471.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+DANHAKL+JOHN+G/26780471.html Thu, 16 Jul 2026 17:03:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Fasano+Jim/26780474.html si-local-file:///var/storage/secattach/20260716/26780474.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Fasano+Jim/26780474.html Thu, 16 Jul 2026 17:03:00 -0400 IQV O.11181775 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Fasano+Jim/26780474.html si-local-file:///var/storage/secattach/20260716/26780474.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IQVIA+HOLDINGS+INC.+++++++For%3A+Jul+14++Filed+by%3A+Fasano+Jim/26780474.html Thu, 16 Jul 2026 17:03:00 -0400 IQV O.11181775 http://www.streetinsider.com/Corporate+News/IQVIA+executive+testifies+before+Congress+on+early+clinical+trials/26778929.html <p>An IQVIA (NYSE: IQV) executive testified before a U.S. House subcommittee, offering recommendations to streamline early-stage clinical drug development in the United States while maintaining existing patient safety standards.</p><p>Dr. Cynthia Verst, president of Design and Delivery Innovation, Research and Development Solutions at IQVIA, appeared before the House Committee on Energy and Commerce Subcommittee on Health during a hearing titled "Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development."</p><p>Her testimony focused on reducing barriers associated with preparing investigational new drug applications, which she described as a significant obstacle for sponsors seeking to initiate first-in-human studies in the http://www.streetinsider.com/Corporate+News/IQVIA+executive+testifies+before+Congress+on+early+clinical+trials/26778929.html Thu, 16 Jul 2026 13:39:52 -0400 IQV http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Press+Releases/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html <p> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com%2F&amp;esheet=54571913&amp;newsitemid=20260716761976&amp;lan=en-US&amp;anchor=IQVIA&amp;index=1&amp;md5=f46016a0994a82f9f3833ec72cca3b05" shape="rect">IQVIA</a> (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.” </p><p> Recommendations were presented by Dr. Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at IQVIA, who highlighted the importance of making the path http://www.streetinsider.com/Business+Wire/IQVIA%26apos%3Bs+Dr.+Cynthia+Verst+Testifies+Before+Congressional+Subcommittee+on+More+Efficient+Path+to+Early+Clinical+Development+in+the+United+States/26778926.html Thu, 16 Jul 2026 13:39:00 -0400 A.38925042 A.50204634 IQV O.00162978 O.03285412 O.11181775 http://www.streetinsider.com/Analyst+PT+Change/IQVIA+Holdings+%28IQV%29+PT+Raised+to+%24252+at+Baird/26759735.html Baird analyst Eric Coldwell raised the price target on IQVIA Holdings (NYSE: IQV) to $252.00 (from $249.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/IQVIA+Holdings+%28IQV%29+PT+Raised+to+%24252+at+Baird/26759735.html Mon, 13 Jul 2026 07:20:30 -0400 IQV http://www.streetinsider.com/Analyst+PT+Change/IQVIA+Holdings+%28IQV%29+PT+Raised+to+%24230+at+Mizuho/26759433.html Mizuho analyst Ann Hynes raised the price target on IQVIA Holdings (NYSE: IQV) to $230.00 (from $215.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/IQVIA+Holdings+%28IQV%29+PT+Raised+to+%24230+at+Mizuho/26759433.html Mon, 13 Jul 2026 06:43:41 -0400 IQV http://www.streetinsider.com/Hot+List/DB+says+buy+these+2+healthcare+stocks+into+Q2+results/26757029.html <p>Deutsche Bank issued Buy ratings on two key healthcare names in a note on Friday, ahead of second-quarter earnings, citing improving sentiment and potential catalysts for both stocks.</p><p>Analyst Justin Bowers highlighted IQVIA Holdings (NYSE: IQV) and Thermo Fisher Scientific (NYSE: TMO) as the stocks in question.</p><p>Deutsche Bank set a price target of $240 on IQVIA, implying 18% upside, with the firm also assigning it a catalyst call buy idea. </p><p>Shares have traded down 10% year-to-date, underperforming peers despite what the bank called "misplaced fears related to the company's business mix and the threat of AI / ML to industry profit http://www.streetinsider.com/Hot+List/DB+says+buy+these+2+healthcare+stocks+into+Q2+results/26757029.html Fri, 10 Jul 2026 15:00:00 -0400 IQV TMO http://www.streetinsider.com/Hot+List/DB+says+buy+these+2+healthcare+stocks+into+Q2+results/26757029.html <p>Deutsche Bank issued Buy ratings on two key healthcare names in a note on Friday, ahead of second-quarter earnings, citing improving sentiment and potential catalysts for both stocks.</p><p>Analyst Justin Bowers highlighted IQVIA Holdings (NYSE: IQV) and Thermo Fisher Scientific (NYSE: TMO) as the stocks in question.</p><p>Deutsche Bank set a price target of $240 on IQVIA, implying 18% upside, with the firm also assigning it a catalyst call buy idea. </p><p>Shares have traded down 10% year-to-date, underperforming peers despite what the bank called "misplaced fears related to the company's business mix and the threat of AI / ML to industry profit http://www.streetinsider.com/Hot+List/DB+says+buy+these+2+healthcare+stocks+into+Q2+results/26757029.html Fri, 10 Jul 2026 15:00:00 -0400 IQV TMO